Type 1 diabetes and COVID-19: The “lockdown effect”

The psychological impact of quarantine and how to reduce it: rapid review of the evidence

(2020) Samantha K Brooks et al.   LANCET

Glycemic Control in Type 1 Diabetes Mellitus During COVID-19 Quarantine and the Role of In-Home Physical Activity

(2020) Gianluca Tornese et al.   Diabetes Technology & Therapeutics

Glycaemic Control Among People with Type 1 Diabetes During Lockdown for the SARS-CoV-2 Outbreak in Italy

(2020) Benedetta Maria Bonora et al.   Diabetes Therapy

Effects of COVID-19 Lockdown on Glucose Control: Continuous Glucose Monitoring Data From People With Diabetes on Intensive Insulin Therapy

(2020) Ernesto Maddaloni et al.   DIABETES CARE

Blood Glucose Control During Lockdown for COVID-19: CGM Metrics in Italian Adults With Type 1 Diabetes

(2020) Brunella Capaldo et al.   DIABETES CARE

Diabetes management mediates the association between sleep duration and glycemic control in youth with type 1 diabetes mellitus

(2019) Sara S. Frye et al.   SLEEP MEDICINE

Diabetes Distress, Intentional Hyperglycemia at Work, and Glycemic Control Among Workers With Type 1 Diabetes

(2019) Ulla M. Hansen et al.   DIABETES CARE

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

(2019) Tadej Battelino et al.   DIABETES CARE

Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring

(2018) Richard M. Bergenstal et al.   DIABETES CARE

Depression and Medication Adherence in the Treatment of Chronic Diseases in the United States: A Meta-Analysis

(2011) Jerry L. Grenard et al.   JOURNAL OF GENERAL INTERNAL MEDICINE